ホーム   >  トピックス   >   オープンアクセス記事   >  オープンアクセス 2021年   > Post-marketing Surveillance of Mepolizumab Use in Patients with Eosinophilic Granulomatosis with Polyangiitis in Japan: Interim Analysis [オープンアクセス]
[オープンアクセス] 
Post-marketing surveillance of mepolizumab use in patients with eosinophilic granulomatosis with polyangiitis in Japan: interim analysis

Post-marketing surveillance of mepolizumab use in patients with eosinophilic granulomatosis with polyangiitis in Japan: interim analysis

  • ABSTRACT
  • INTRODUCTION
  • TARGET AND METHOD
    • 1 Study design
    • 2 Patients
    • 3 Mepolizumab safety profile
    • 4 Clinical observations
    • 5 Sample size and statistical analysis
  • RESULTS
    • 1 Patient population
    • 2 Mepolizumab safety profile
    • 3 Clinical observations
  • DISCUSSION
  • CONCLUSION
    • CONFLICTS of INTERESTS
    • ACKNOWLEDGMENTS
  • REFERENCES

▲このページの上へもどる